Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Enforcement-nir
Subscribe today for access to
Articles and Reports
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It
False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.
OIG Semi-Annual Report Calls Out Drug, Genetic, and COVID-19 Testing Fraud
These three lab testing areas were the main sources of fraud and abuse revealed in the OIG’s latest Semi-Annual Report to Congress.
OIG Mid-Year Work Plan Update Adds PAMA-Focused Lab Item
...
Already a member? Log in here
Focus Diagnostics Simplexa Test Kit Faces Recall
...
Already a member? Log in here
Government Scrutiny of Theranos Increases
...
Already a member? Log in here
DOJ Report Reveals Fraud and Abuse Recoveries Declined in Fiscal Year 2015
...
Already a member? Log in here
Recent $3.9 Million Settlement and Task Force Announcement Focus Attention on Health Care Information Security
From - National Intelligence Report
A $3.9 million settlement arising from a potential HIPAA breach and an announcement regarding a U.S. Department of Health and Human Services Task Force emphasize the…
